These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6972459)

  • 1. [Cell-mediated immunity. The cellular network in its induction and manifestation].
    Saito K
    Nihon Saikingaku Zasshi; 1980 Nov; 35(6):721-37. PubMed ID: 6972459
    [No Abstract]   [Full Text] [Related]  

  • 2. Cooperation between mononuclear phagocytes and lymphocytes in immunity.
    Unanue ER
    N Engl J Med; 1980 Oct; 303(17):977-85. PubMed ID: 6774253
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of T cell differentiation markers in antigen-specific and lectin-dependent cellular cytotoxicity mediated by T8+ and T4+ human cytotoxic T cell clones directed at class I and class II MHC antigens.
    Spits H; Borst J; Terhorst C; de Vries JE
    J Immunol; 1982 Oct; 129(4):1563-9. PubMed ID: 6980945
    [No Abstract]   [Full Text] [Related]  

  • 4. T lymphocyte-macrophage interactions in cellular antibacterial immunity.
    Hahn H; Kaufmann SH
    Immunobiology; 1982 Apr; 161(3-4):361-8. PubMed ID: 6807832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of delayed hypersensitivity.
    McCluskey RT; Cohen S
    Pathobiol Annu; 1972; 2():111-28. PubMed ID: 4589745
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance and biological function of class II MHC molecules. Rous-Whipple Award lecture 1985.
    Benacerraf B
    Am J Pathol; 1985 Sep; 120(3):334-43. PubMed ID: 3929612
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
    Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
    Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A: a tool for analyzing the function of class I MHC antigen-reactive T cells in vivo.
    Hodgkin PD; Dixon JE; Andrus L; Lafferty KJ
    Transplant Proc; 1984 Aug; 16(4):968-9. PubMed ID: 6611620
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of cell-mediated immunity in bacterial infections.
    Hahn H; Kaufmann SH
    Rev Infect Dis; 1981; 3(6):1221-50. PubMed ID: 6805064
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1.
    Kaye J; Janeway CA
    Lymphokine Res; 1984; 3(4):175-82. PubMed ID: 6436584
    [No Abstract]   [Full Text] [Related]  

  • 11. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins.
    Miller SD; Clatch RJ; Pevear DC; Trotter JL; Lipton HL
    J Immunol; 1987 Jun; 138(11):3776-84. PubMed ID: 2438327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of graft-vs-host disease by adoptive transfer of a class II antigen-specific murine T-cell clone.
    Shih CC; Truitt RL
    Prog Clin Biol Res; 1987; 244():439-47. PubMed ID: 3116558
    [No Abstract]   [Full Text] [Related]  

  • 13. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD
    J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity.
    Valentine FT; Lawrence HS
    Adv Intern Med; 1971; 17():51-93. PubMed ID: 4147307
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
    Lowry RP; Gurley KE
    Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-T cell interactions in cell-mediated immune responses to major histocompatibility complex antigens.
    Rich RR; Rich SS
    Crit Rev Immunol; 1983; 4(2):129-68. PubMed ID: 6221885
    [No Abstract]   [Full Text] [Related]  

  • 18. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice.
    Gerety SJ; Clatch RJ; Lipton HL; Goswami RG; Rundell MK; Miller SD
    J Immunol; 1991 Apr; 146(7):2401-8. PubMed ID: 1706400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in expression of MHC products between several H-2-restricted CTL clones.
    Hauptfeld V; Braciale TJ; Shreffler DC
    J Immunol; 1982 May; 128(5):2026-31. PubMed ID: 6977581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity: induction and expression of T-cell function.
    Lawman MJ
    J Am Vet Med Assoc; 1982 Nov; 181(10):1022-9. PubMed ID: 6294025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.